INTELLIA THERAPEUTICS INC

About

Intellia Therapeutics Inc. is a clinical-stage biotechnology company focused on developing curative genome editing therapies using CRISPR/Cas9 technology. The company specializes in both in vivo programs, where the editing is done inside the body, and ex vivo treatments, where cells are modified outside the body before being administered to patients. Intellia aims to treat a range of diseases by directly editing the genetic causes of severe conditions, establishing itself as a key player in the advanced genetic medicine sector.